Rafael Tourinho-Barbosa, Rafael Sanchez-Salas, Arjun Sivaraman, Rafael Castilho Borges, Luigi Candela, Lucas Teixeira Batista, Nathalie Cathala, Annick Mombet, Giancarlo Marra, Lara Rodriguez Sanchez, Chahrazad Bey Boumezrag, Camille Lanz, Petr Macek, Xavier Cathelineau, Fernando Korkes
OBJECTIVE: To present the patient-reported QoL outcomes from a prospective, randomized controlled trial comparing the use of pelvic floor muscle training (PFMT) and duloxetine after robot-assisted radical prostatectomy (RARP). METHODS: We identified 213 men with organ-confined disease having post-RARP urinary incontinence who were randomly assigned to received PFMT, duloxetine, combined PFMT-duloxetine and pelvic floor muscle home exercises. Urinary symptoms burden was measured by marked clinical important difference improvement (MCID) defined by using the International Prostate Symptom Score(IPSS) difference of -8 points(ΔIPSS ≤ -8)...
January 26, 2024: Urology